Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04595994
Recruitment Status : Recruiting
First Posted : October 22, 2020
Last Update Posted : July 8, 2021
Sponsor:
Information provided by (Responsible Party):
Grupo Espanol de Investigacion en Sarcomas